We fuel the ascent of tech and biotech pioneers.
Investing in pre-seed and seed stage startups scaling the highest peaks of innovation.

Teams We're Backing
Fauna Bio is an AI-Enabled platform company leveraging its proprietary animal-based genomics database to discover new drugs. Their first asset approaches Pulmonary Hypertension associated heart disease.
​
Read more here.
Our Team

Managing Partner
Colin Maraganore
Colin brings a unique operator-investor perspective to venture capital as a founding Principal of Abeja Ventures’ $125M emerging biotechnology fund, where he and Nelly co-led the evaluation of 200+ annual opportunities and explored co-investment opportunities with 100+ institutional partners. His hybrid expertise stems from 9 years of hands-on leadership at now clinical-stage biotechs – including BioAge Labs, Rejuvenation Technologies, and Earli, Inc. – giving him rare operational fluency in therapeutic development from preclinical validation through clinical translation. Colin holds a BS in Psychology and Neuroscience from the University of Minnesota.

Managing Partner
Nelly Weiser
A bioengineer by training and passion, Nelly was a founding member and Principal at Abeja Ventures, a $125M emerging biotechnology VC fund investing in Series A therapeutics and digital health companies. She brings deep expertise in designing, building, and investing in innovative ventures. Prior to Abeja, Nelly was a Strategy and Operations Lead at Moment Biosciences, an mRNA therapeutics company, and held research positions at Earli, Inc. and the Khalil Lab at Boston University. Nelly is also an angel investor, having previously invested in companies such as Ripple Foods and Zus Health. Nelly holds a BS from Stanford and a MS in Bioengineering from BU.

Managing Partner
Ishtpreet Singh
Ishtpreet brings a uniquely multifaceted perspective to early-stage investing, drawing from extensive experience in Silicon Valley and politics. With over 8 years at Google and Waymo, he has driven critical initiatives in policy, government affairs, and product strategy. His political acumen was honed through service on White House Advance Teams for two U.S. Presidents. Ishtpreet’s venture capital experience includes 20% work with GV (Google Ventures), a top tier firm. As a prolific angel investor, he has built a portfolio of 50 companies. Ishtpreet holds an MBA from the University of Chicago Booth School of Business, complementing his strong foundation in technology and policy.
